Company Filing History:
Years Active: 2023-2025
Title: Matthew Culpepper: Innovator in Droplet Delivery Technology
Introduction
Matthew Culpepper is an accomplished inventor based in Boone, NC (US). He has made significant contributions to the field of respiratory technology, particularly through his innovative droplet delivery devices. With a total of 2 patents to his name, Culpepper is recognized for his expertise and creativity in developing solutions that enhance fluid delivery systems.
Latest Patents
Culpepper's latest patents focus on a droplet delivery device designed for efficient fluid ejection. The device features a housing with a mouthpiece port or outlet from a nasal device, allowing for the release of fluid droplets. It includes a fluid reservoir and an ejector bracket that houses a membrane positioned between a mesh with multiple openings and a vibrating member. This vibrating member is coupled to an electronic transducer, such as an ultrasonic transducer. When activated, the transducer vibrates the member, causing the membrane to push fluid from the reservoir through the mesh, generating droplets that are ejected through the outlet.
Career Highlights
Culpepper's work at Pneuma Respiratory, Inc. has been pivotal in advancing respiratory technology. His innovative designs and patents have the potential to improve patient care and enhance the effectiveness of respiratory treatments. His dedication to research and development has established him as a key figure in the industry.
Collaborations
Culpepper collaborates with talented professionals in his field, including Charles Eric Hunter and Michael Scoggin. These partnerships foster a creative environment that encourages innovation and the development of cutting-edge technologies.
Conclusion
Matthew Culpepper is a notable inventor whose work in droplet delivery technology is making a significant impact in the field of respiratory health. His patents and collaborations reflect his commitment to improving fluid delivery systems, ultimately benefiting patients and healthcare providers alike.